Select a medication above to begin.
Fiasp
insulin aspart
Adult Dosing .
Dosage forms: INJ (PenFill U-100 cartridge): 100 units per mL; INJ (PumpCart U-100 cartridge): 100 units per mL; INJ (FlexTouch U-100 pen): 100 units per mL; INJ (U-100 vial): 100 units per mL
Dosage Form Details
- [formulation clarification]
- Info: contains niacinamide (inactive ingredient) for faster absorption
Special Note
- [additional info]
- Info: search Insulin Product Comparisons for comparison of onset, peak, duration, dosage form, and mixing compatibility
diabetes mellitus, type 1
- [intermittent SC injection]
- Dose: individualize dose SC bid-qid; Start: 50-60% x (0.4-0.5 units/kg/day) SC in divided doses, may adjust dose by 1-4 units or 5-10% 1-2x/wk; Info: usual total daily insulin requirement 0.4-1 units/kg/day (basal + prandial); give at start or within 20min of meal; use with intermediate-acting or long-acting insulin; dose adjustment may be needed during pregnancy and/or immediately postpartum; onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
- [continuous SC infusion]
- Dose: individualize dose via continuous SC infusion pump; Info: usual total daily insulin requirement 0.4-1 units/kg/day (basal + prandial); dose adjustment may be needed during pregnancy and/or immediately postpartum; onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
- [IV route]
- Dose: individualize dose via IV infusion; Info: refer to institutional protocol; dose adjustment may be needed during pregnancy and/or immediately postpartum
diabetes mellitus, type 2
- [intermittent SC injection]
- Dose: individualize dose SC bid-qid; Start: 4 units SC qd or 10% of basal insulin dose SC qd, may incr. dose by 1-2 units or 10-15% 2x/wk; Info: give at start or within 20min of meal; use with intermediate-acting or long-acting insulin; dose adjustment may be needed during pregnancy and/or immediately postpartum; onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
- [continuous SC infusion]
- Dose: individualize dose via continuous SC infusion pump; Info: dose adjustment may be needed during pregnancy and/or immediately postpartum; onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
- [IV route]
- Dose: individualize dose via IV infusion; Info: refer to institutional protocol; dose adjustment may be needed during pregnancy and/or immediately postpartum
renal dosing
- [see below]
- renal impairment: consider decr. usual start dose
- HD: consider decr. usual start dose; no supplement after dialysis; PD: consider decr. usual start dose; no supplement
hepatic dosing
- [see below]
- hepatic impairment: not defined, caution advised
Peds Dosing .
- Dosage forms: INJ (PenFill U-100 cartridge): 100 units per mL; INJ (PumpCart U-100 cartridge): 100 units per mL; INJ (FlexTouch U-100 pen): 100 units per mL; INJ (U-100 vial): 100 units per mL
Dosage Form Details
- [formulation clarification]
- Info: contains niacinamide (inactive ingredient) for faster absorption
Special Note
- [additional info]
- Info: search Insulin Product Comparisons for comparison of onset, peak, duration, dosage form, and mixing compatibility
diabetes mellitus, type 1
- [intermittent SC injection, 2 yo and older]
- Dose: individualize dose SC bid-qid; Info: usual total daily insulin requirement 0.4-1 units/kg/day (basal + prandial); adolescents may require higher doses; give at start or within 20min of meal; use with intermediate-acting or long-acting insulin; onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
- [continuous SC infusion, 2 yo and older]
- Dose: individualize dose via continuous SC infusion pump; Info: usual total daily insulin requirement 0.4-1 units/kg/day (basal + prandial); adolescents may require higher doses; onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
diabetes mellitus, type 2
- [intermittent SC injection]
- Dose: individualize dose SC bid-qid; Info: give at start or within 20min of meal; use with intermediate-acting or long-acting insulin; onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
- [continuous SC infusion]
- Dose: individualize dose via continuous SC infusion pump; Info: onset 2.5min, peak 63min, duration 5-7h (rapid-acting insulin)
renal dosing
- [see below]
- renal impairment: consider decr. usual start dose
- HD: consider decr. usual start dose; no supplement after dialysis; PD: consider decr. usual start dose; no supplement
hepatic dosing
- [see below]
- hepatic impairment: not defined, caution advised
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- hypoglycemia
- caution: hypoglycemia unawareness
- caution: illness
- caution: stress
- caution: hypokalemia risk
- caution: renal impairment
- caution: hepatic impairment
- caution: visual impairment (pen form)
- caution: localized cutaneous amyloidosis
- caution: lipodystrophy
Drug Interactions .
Overview
insulin
insulin
- affects growth hormone diagnostic test results
- antidiabetic agent
- hypokalemia
zinc (inactive ingredient)
heavy metal
- heavy metal
Avoid/Use Alternative
- alpelisib
- arsenic trioxide
- ethanol (alcoholic beverage)
- inavolisib
- macimorelin
- repaglinide
- rosiglitazone
Monitor/Modify Tx
- abiraterone acetate
- acarbose
- acebutolol
- acetazolamide
- albuterol
- albuterol inhaled
- alclometasone topical
- aloe
- alogliptin
- amcinonide topical
- amphotericin
- arformoterol inhaled
- aripiprazole bimonthly injection
- aripiprazole lauroxil
- aripiprazole monthly injection
- aripiprazole oral
- asenapine
- ashwagandha
- asparaginase
- aspirin
- atazanavir
- azilsartan medoxomil
- benazepril
- berberine
- betamethasone
- betamethasone topical
- bexagliflozin
- bexarotene
- bismuth subsalicylate
- bortezomib
- brentuximab vedotin
- brexpiprazole
- brigatinib
- bromocriptine
- budesonide
- bumetanide
- calaspargase
- canagliflozin
- candesartan cilexetil
- capivasertib
- carfilzomib
- cariprazine
- carvedilol
- cassia cinnamon
- ceritinib
- cetuximab
- chloroquine
- chlorothiazide
- chlorthalidone
- chromium
- ciprofloxacin
- cisplatin
- clarithromycin
- clobetasol topical
- clocortolone topical
- clonidine
- clozapine
- colesevelam
- copanlisib
- corticotropin
- cortisone
- crizotinib
- dabrafenib
- danazol
- dapagliflozin
- darunavir
- decitabine
- deflazacort
- delafloxacin
- desogestrel (contraceptive)
- desonide topical
- desoximetasone topical
- dexamethasone
- diazoxide
- dichlorphenamide
- dienogest (contraceptive)
- diflorasone topical
- digoxin
- dinutuximab
- disopyramide
- drospirenone (contraceptive)
- dulaglutide
- edetate calcium disodium
- eleuthero
- emapalumab
- empagliflozin
- enfortumab vedotin
- ensartinib
- ephedra
- epinephrine
- ertugliflozin
- estetrol (contraceptive)
- estradiol (contraceptive)
- estradiol (hormone replacement)
- estrogens, conjugated (hormone replacement)
- estrogens, esterified (hormone replacement)
- ethacrynic acid
- ethinyl estradiol (contraceptive)
- ethinyl estradiol (hormone replacement)
- ethionamide
- ethynodiol (contraceptive)
- etonogestrel (contraceptive)
- everolimus
- exenatide
- fenofibrate
- fenofibric acid
- fenugreek
- flaxseed
- fludrocortisone
- fluocinolone otic
- fluocinolone topical
- fluocinonide topical
- fluoxetine
- flurandrenolide topical
- fluticasone propionate topical
- formoterol inhaled
- fosamprenavir
- foscarnet
- fosfomycin injection
- fosphenytoin
- furosemide
- garlic
- gemfibrozil
- ginkgo
- ginseng, American
- ginseng, Asian
- glimepiride
- glipizide
- glucagon
- glyburide
- goserelin
- gymnema
- halcinonide topical
- halobetasol topical
- hydrochlorothiazide
- hydrocortisone
- hydrocortisone topical
- hydroxychloroquine
- iloperidone
- indapamide
- irbesartan
- isocarboxazid
- isoniazid
- isoproterenol
- lanreotide
- lenalidomide
- leuprolide
- levalbuterol inhaled
- levofloxacin
- levonorgestrel (contraceptive)
- levothyroxine
- licorice
- linagliptin
- linezolid
- liothyronine
- liraglutide
- lisinopril
- lithium
- lixisenatide
- lopinavir/ritonavir
- lorlatinib
- losartan
- lumateperone
- lurasidone
- lutetium Lu 177 dotatate
- magnesium citrate
- magnesium salicylate
- mannitol
- mecasermin
- medroxyprogesterone (contraceptive)
- megestrol
- metformin
- methazolamide
- methylprednisolone
- methyltestosterone
- metoclopramide
- metolazone
- metreleptin
- mifepristone
- miglitol
- milk thistle
- milsaperidone
- mometasone topical
- motixafortide
- moxifloxacin
- nadolol
- nateglinide
- necitumumab
- nelfinavir
- niacin (vitamin B3)
- nilotinib
- norelgestromin (contraceptive)
- norepinephrine
- norethindrone (contraceptive)
- norgestimate (contraceptive)
- norgestrel (contraceptive)
- octreotide
- ofloxacin
- olanzapine
- olmesartan medoxomil
- olodaterol inhaled
- osilodrostat
- paliperidone
- paltusotine
- pamidronate
- panitumumab
- pasireotide
- pegaspargase
- peginterferon alfa 2a
- pegvisomant
- pentamidine
- pentoxifylline
- phenelzine
- phenylephrine
- phenytoin
- pindolol
- pioglitazone
- plozasiran
- polyethylene glycol
- polyethylene glycol/electrolytes
- posaconazole
- pramlintide
- prednicarbate topical
- prednisolone
- prednisone
- pseudoephedrine
- quetiapine
- quinine
- ribose
- risperidone
- ritonavir
- sacituzumab govitecan
- sacrosidase
- salmeterol inhaled
- salsalate
- saxagliptin
- segesterone (contraceptive)
- selinexor
- semaglutide
- sirolimus albumin-bound
- sitagliptin
- sodium benzoate
- sodium phenylacetate
- sodium phenylbutyrate
- sodium polystyrene sulfonate
- sodium thiosulfate
- somapacitan
- somatrogon
- somatropin
- sotagliflozin
- sotalol
- spironolactone
- sucralfate
- sulfadiazine
- sulfamethoxazole
- sulfasalazine
- sulfate bowel prep
- sunitinib
- tafasitamab
- telmisartan
- temsirolimus
- teprotumumab
- terbutaline
- tesamorelin
- testosterone
- thyroid
- timolol
- tipranavir
- tirzepatide
- topiramate
- torsemide
- tramadol
- trandolapril
- tranylcypromine
- triamcinolone
- triamcinolone topical
- triamterene
- triptorelin
- turmeric
- valsartan
- vamorolone
- vilanterol inhaled
- vorinostat
- ziprasidone
- zonisamide
Adverse Reactions .
Serious Reactions
- hypersensitivity reaction
- anaphylaxis
- hypoglycemia
- hypokalemia
Common Reactions
- hypoglycemia
- URI
- infusion site reaction
- headache
- UTI
- diarrhea
- back pain
- nausea
- hypersensitivity reaction
- injection site reaction
- injection site lipodystrophy
- fever (peds patients)
- vomiting (peds patients)
- weight gain
- edema, peripheral
- localized cutaneous amyloidosis
Safety/Monitoring .
Monitoring Parameters
Cr at baseline; K if hypokalemia risk
Pregnancy/Lactation .
Pregnancy
Clinical Summary
may use during pregnancy; drug of choice for diabetes use during pregnancy; dose adjustment may be needed during pregnancy and/or immediately postpartum; no known risk of fetal harm based on human data
Lactation
Clinical Summary
may use while breastfeeding; no human data available, though risk of infant harm not expected based on drug properties; possible risk of delayed milk production based on conflicting human data
Pharmacology .
Metabolism: for insulin aspart: liver, kidney, fat; CYP450: none
Excretion: for insulin aspart: urine; Half-life: 1.1h; Info: onset, peak, duration vary among insulin products and routes; search Insulin Product Comparisons for more info
Subclass: Diabetes: Insulins
Mechanism of Action
for insulin aspart: stimulates peripheral glucose uptake, inhibits hepatic glucose production, inhibits lipolysis and proteolysis, regulating glucose metabolism (rapid-acting insulin)
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.